PetMed Express logo

PetMed ExpressNASDAQ: PETS

Profile

Sector:

Healthcare

Country:

United States

IPO:

26 April 1999

Next earnings report:

07 February 2025

Last dividends:

11 August 2023

Next dividends:

N/A
$96.91 M
-84%vs. 3y high
45%vs. sector
-vs. 3y high
-vs. sector
-77%vs. 3y high
39%vs. sector
-83%vs. 3y high
9%vs. sector

Price

after hours | Thu, 21 Nov 2024 00:45:13 GMT
$4.69+$0.17(+3.68%)
$59.57 M$60.00 M
$59.57 M$2.33 M

Analysts recommendations

Institutional Ownership

PETS Latest News

Here's Why PetMed (PETS) is a Strong Momentum Stock
zacks.com14 November 2024 Sentiment: POSITIVE

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

PetMed Express: Why (And Why Not) The Rebound Could Continue
seekingalpha.com12 November 2024 Sentiment: POSITIVE

PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance.

Pets at Home's veterinary offering drives revenue growth
proactiveinvestors.co.uk01 August 2024 Sentiment: POSITIVE

Pets at Home Group PLC (LSE:PETS) is seeing a noticeable increase in average spend and visits for its veterinary services, which is helping to offset a decline in retail spend. Vet Group revenues surged more than 17% in the first half of its 2025 financial year, leading to a 1% growth in group-wide revenues to £441.1 million despite a 0.8% dip in retail sales.

PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
globenewswire.com24 June 2024 Sentiment: NEGATIVE

Investors can contact the law firm at no cost to learn more about recovering their losses

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
accesswire.com17 June 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
globenewswire.com14 June 2024 Sentiment: NEGATIVE

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).   Such investors are advised to contact Danielle Peyton at [email protected]  or 646-581-9980, ext. 7980.

PetMed Express, Inc. (PETS) Q4 2024 Earnings Call Transcript
seekingalpha.com11 June 2024 Sentiment: POSITIVE

PetMed Express, Inc. (NASDAQ:PETS ) Q4 2024 Earnings Conference Call June 11, 2024 4:30 PM ET Company Participants John Mills - Investor Relations, ICR Sandra Campos - Chief Executive Officer and President Christine Chambers - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Erin Wright - Morgan Stanley Operator Greetings and welcome to PetMed Express Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.

PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
globenewswire.com11 June 2024 Sentiment: POSITIVE

DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2024.

Pets At Home Purrs As FY Profits Meet Updated Guidance
forbes.com29 May 2024 Sentiment: POSITIVE

Pets at Home was one of the FTSE 250's best performers on Wednesday, as the retailer announced full-year results in line with January's downgraded guidance.

Pets at Home holds dividend and launches buyback, but sales slip in new year
proactiveinvestors.co.uk29 May 2024 Sentiment: POSITIVE

Pets at Home Group PLC (LSE:PETS) announced plans for new £25 million share buyback after what it said was a "foundational year" as sales growth slowed less than expected in the final quarter.  Largely the preliminary results for the 52 weeks to 28 March were in line with pre-announced guidance from the pets-and-vets chain.

  • 1(current)
  • 2

What type of business is PetMed Express?

PetMed Express Inc, along with its subsidiaries operating under the name 1-800-PetMeds, is a national pharmacy for pets. The company sells prescription and over-the-counter medications for pets, as well as other health products for dogs, cats, and horses directly to consumers. PetMed Express, Inc. was founded in 1996, and its headquarters are located in Delray Beach, Florida.

What sector is PetMed Express in?

PetMed Express is in the Healthcare sector

What industry is PetMed Express in?

PetMed Express is in the Pharmaceutical Retailers industry

What country is PetMed Express from?

PetMed Express is headquartered in United States

When did PetMed Express go public?

PetMed Express initial public offering (IPO) was on 26 April 1999

What is PetMed Express website?

https://www.1800petmeds.com

Is PetMed Express in the S&P 500?

No, PetMed Express is not included in the S&P 500 index

Is PetMed Express in the NASDAQ 100?

No, PetMed Express is not included in the NASDAQ 100 index

Is PetMed Express in the Dow Jones?

No, PetMed Express is not included in the Dow Jones index

When was PetMed Express the previous earnings report?

No data

When does PetMed Express earnings report?

The next expected earnings date for PetMed Express is 07 February 2025